Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
21.1M
-
Shares change
-
+13M
-
Total reported value, excl. options
-
$37M
-
Value change
-
+$22.2M
-
Put/Call ratio
-
0.91
-
Number of buys
-
64
-
Number of sells
-
-17
-
Price
-
$1.75
Significant Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q1 2023
105 filings reported holding SMMT - Summit Therapeutics Inc. - COM as of Q1 2023.
Summit Therapeutics Inc. - COM (SMMT) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.1M shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (6.3M shares), BlackRock Inc. (1.85M shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1.69M shares), VANGUARD GROUP INC (1.47M shares), GEODE CAPITAL MANAGEMENT, LLC (1.09M shares), MILLENNIUM MANAGEMENT LLC (904K shares), AWM Investment Company, Inc. (800K shares), MORGAN STANLEY (770K shares), Steward Partners Investment Advisory, LLC (631K shares), and CSS LLC/IL (523K shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.